Effects of bortezomib on HIF-1 and HIF-2 transcriptional activities
Bortezomib is the first proteasomal inhibitor (PI) to be used therapeutically in humans for treating relapse cases of multiple myeloma and mantle cell lymphoma. A proposed mechanism is that it prevents proteasomal degradation of pro-apoptotic proteins, leading to enhance apoptosis. Although the alp...
Main Author: | Abd Aziz, Noraini |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2013
|
Subjects: | |
Online Access: | http://psasir.upm.edu.my/id/eprint/48690/1/FBSB%202013%2039R.pdf |
Similar Items
-
Bortezomib attenuates HIF-1- but not HIF-2-mediated transcriptional activation
by: Abd Aziz, Noraini, et al.
Published: (2015) -
The marine-derived HIF-1α inhibitor, Yardenone 2, reduces prostate cancer cell proliferation by targeting HIF-1 target genes
by: Siyong Peng, et al.
Published: (2024-07-01) -
Regulation of carcinogenesis, angiogenesis and metastasis by the proprotein convertases (PCs) : a new potential strategy in cancer therapy /
by: Khatib, A-Majid
Published: (2006) -
Role of proteases in oral carcinogenesis: Insights into the cancer degradome and therapeutic implications
by: Gargi S. Sarode, et al.
Published: (2024-06-01) -
Inherent DNA‐binding specificities of the HIF‐1α and HIF‐2α transcription factors in chromatin
by: Smythies, J, et al.
Published: (2018)